Ticker

No recent analyst price targets found for BRCNF.

Latest News for BRCNF

Burcon Closes Second Tranche of Non-Brokered Private Placement of Convertible Debentures of up to $6.9 Million

Vancouver, British Columbia--(Newsfile Corp. - February 27, 2026) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in plant-based protein innovation, is pleased to announce the closing of the second tranche of its previously announced non-brokered private placement (see news releases of the Company dated January 2, 2026 and January 9, 2026) of…

Newsfile Corp • Feb 27, 2026
Burcon Announces Results of Shareholder Meeting

Vancouver, British Columbia--(Newsfile Corp. - February 20, 2026) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) (the "Burcon" or the "Company"), a global technology leader in plant-based protein innovation, is pleased to announce that all meeting matters put forth to shareholders, as voted on by shareholders, and where applicable, disinterested shareholders, were duly approved at its 2026 special…

Newsfile Corp • Feb 20, 2026
Stonegate Updates Coverage on Burcon Nutrascience Corporation (BU) FY26 Q3

Dallas, Texas--(Newsfile Corp. - February 12, 2026) - Burcon Nutrascience Corporation (TSX: BU): Stonegate Capital Partners updates their coverage on Burcon Nutrascience Corporation (TSX: BU). Burcon's Galesburg production facility represents a pivotal transition from development-stage operations to commercial scale, with 3Q26 revenue of $739,000 reflecting approximately 107% quarter-over-quarter growth driven by…

Newsfile Corp • Feb 12, 2026

🧮 Earnings Move Analyzer

Insider Trading

No insider trades found for BRCNF.

No Senate trades found for BRCNF.

No House trades found for BRCNF.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top